Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
University of Illinois at Chic
Search grants from University of Illinois at Chic
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Characterization of the Lysogenic Pathway in P. acnes Bacteriophages
The Zebrafish Connectome
Origin of Prostate Tumors
Isotopic Composition of Atmospheric Carbon Monoxide
Measurements of Atmospheric Composition Using Infrared Techniques
Recently added grants:
Translational analysis of cerebrovascular dysfunction in aging
The role of proopiomelanocortin neurons in age-related cognitive decline
APP function in gila and implications for Alzheimer's therapies
The Effects of ERK2-Induced Phosphorylation of METTL3 on N6-methyladenosine (m6A) mRNA Methylation in Melanoma
Treatment Options for Insomnia for ESRD
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA085081-003
Application #
6688593
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chic
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chic
NIH 2002
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chic
Comments
Be the first to comment on this grant